SCHEMBL5601992

SCHEMBL5601992

CCOC(=O)c1c[nH]n(-c2ccc(Cl)cc2)c1=O

nearest known ligand 0.80

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.80
MAPT P10636 2/20 0.76
MAPK1 P28482 1/20 0.53
KDM4E B2RXH2 5/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KMT2A Q03164 2/20 0.46
CDC25B P30305 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
CHRNA7 P36544 2/20 0.45
DPP4 P27487 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GCGR P47871 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260172 0.86 ALDH1A1 (0.80) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL5599513 0.86 ALDH1A1 (0.80) ALDH1A1MAPTKDM4EKMT2ACHRNA7
SCHEMBL199471 0.86 MAPT (1.00) ALDH1A1MAPTKDM4ESMN1; SMN2KMT2A
SCHEMBL5599197 0.83 ALDH1A1 (0.60) ALDH1A1MAPTMAPK1KDM4ESMN1; SMN2
SCHEMBL1258132 0.80 MAPT (0.66) ALDH1A1MAPTMAPK1KDM4EKMT2A
SCHEMBL1260514 0.79 MAPT (0.68) ALDH1A1MAPTMAPK1KDM4ESMN1; SMN2
SCHEMBL1259728 0.76 MAPT (0.71) ALDH1A1MAPTMAPK1KDM4ESMN1; SMN2
SCHEMBL17495345 0.75 MAPT (0.63) ALDH1A1MAPTMAPK1KDM4ESMN1; SMN2
SCHEMBL5762071 0.74 MAPK1 (0.65) ALDH1A1MAPTMAPK1KDM4ESMN1; SMN2
SCHEMBL6272160 0.73 ALDH1A1 (0.60) ALDH1A1MAPTMAPK1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007026215-A1 PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING? THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2007-03-08 WO disclosed